FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Elise Kohn

Research Profile

Disorders

Chemicals & Drugs

Physiology

Anatomy

Co-author Network

Publications

TOP 3
Jung-min Lee; Lori M Minasian; Anne M Noonan; Jennifer Squires; Bradford J Wood; Minshu Yu; Christina Annunziata; Nilofer S Azad; Katherine R Calvo; John L Hays; Nicole Houston; Elise C Kohn
Feasibility and safety of sequential research-related tumor core biopsies in clinical trials.
Elise C Kohn; Jean Hurteau
Ovarian cancer : making its own rules-again.
Christina M Annunziata; Manuela Buzoianu; Robert L Coleman; Nicole D Houston; Elise C Kohn; Patricia M LoRusso; Gabriel Robbie; Robert Lechleider
Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Elise Kohn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jung-min Lee; Lori M Minasian; Anne M Noonan; Jennifer Squires; Bradford J Wood; Minshu Yu; Christina Annunziata; Nilofer S Azad; Katherine R Calvo; John L Hays; Nicole Houston; Elise C Kohn
Feasibility and safety of sequential research-related tumor core biopsies in clinical trials.
Cancer 2013;119(7):1357-64.
2013: Elise C Kohn; Jean Hurteau
Ovarian cancer : making its own rules-again.
Cancer 2013;119(3):474-6.
2013: Christina M Annunziata; Manuela Buzoianu; Robert L Coleman; Nicole D Houston; Elise C Kohn; Patricia M LoRusso; Gabriel Robbie; Robert Lechleider
Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors.
Investigational new drugs 2013;31(1):77-84.
2012: Minshu Yu; Alyssa Perroy; Victoria Virador; Amanda Walker; Riccardo Alessandro; Ryan Henning; Geoffrey Kim; Elise C Kohn
L-asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer.
Journal of cellular and molecular medicine 2012;16(10):2369-78.
2012: Simona Taverna; Giacomo De Leo; Anna Maria Flugy; Elise C Kohn; Serena Meraviglia; Laura Saieva; Alessandra Santoro; Riccardo Alessandro
Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis.
International journal of cancer. Journal international du cancer 2012;130(9):2033-43.
2012: Geoffrey Kim; Junbai Wang; Minshu Yu; Christina Annunziata; Ben Davidson; Ryan Henning; Thea Hetland; Elise C Kohn
Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome.
Cancer 2012;118(6):1543-53.
2012: Marco Mineo; Simona Taverna; Riccardo Alessandro; Giacomo De Leo; Anna Flugy; Susan H Garfield; Elise C Kohn
Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion.
Angiogenesis 2012;15(1):33-45.
2011: Ebony Hoskins; Jaime Rodriguez-Canales; Ben Davidson; Wafic Elmasri; Jasmine Han; Shing Han; Stephen M Hewitt; Elise C Kohn
Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells.
Gynecologic oncology 2011;122(3):656-62.
2011: Chiara Corrado; Stefania Raimondo; Anna Maria Flugy; Simona Fontana; Alessandra Santoro; Giorgio Stassi; Anna Marfia; Flora Iovino; Ralph Arlinghaus; Elise C Kohn; Giacomo De Leo; Riccardo Alessandro
Carboxyamidotriazole inhibits cell growth of imatinib-resistant chronic myeloid leukaemia cells including T315I Bcr-Abl mutant by a redox-mediated mechanism.
Cancer letters 2011;300(2):205-14.
2011: Jasmine J Han; Minshu Yu; Nicole Houston; Seth M Steinberg; Elise C Kohn
Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers.
Gynecologic oncology 2011;120(1):5-10.
2010: J-M Lee; Elise C Kohn
Proteomics as a guiding tool for more effective personalized therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21 Suppl 7():vii205-10.
2010: John L Hays; Geoffrey Kim; Iulia Giuroiu; Elise C Kohn
Proteomics and ovarian cancer: integrating proteomics information into clinical care.
Journal of proteomics 2010;73(10):1864-72.
2010: Christina Annunziata; Helene Tuft Stavnes; Lilach Kleinberg; Aasmund Berner; Lidia F Hernandez; Michael J Birrer; Seth M Steinberg; Ben Davidson; Elise C Kohn
Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer.
Cancer 2010;116(13):3276-84.
2010: Lídia Hernandez; Sarah C Hsu; Ben Davidson; Michael J Birrer; Elise C Kohn; Christina M Annunziata
Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer.
Cancer research 2010;70(10):4005-14.
2010: Gisele Sarosy; Mahrukh M Hussain; Michael Seiden; Arlan F Fuller; Najmosama Nikrui; Annekathryn Goodman; Lori M Minasian; Eddie Reed; Seth M Steinberg; Elise C Kohn
Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancer.
Cancer 2010;116(6):1476-84.
2010: J-M Lee; Gisele Sarosy; Christina Annunziata; Nilofer S Azad; Lori M Minasian; Herb Kotz; J Squires; N Houston; Elise C Kohn
Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity.
British journal of cancer 2010;102(3):495-9.
2010: Christina Annunziata; Amanda J Walker; Lori M Minasian; Minshu Yu; Herb Kotz; Bradford J Wood; Katherine R Calvo; Peter Choyke; Daniel Kimm; Seth M Steinberg; Elise C Kohn
Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(2):664-72.
2010: Nabila Rasool; William LaRochelle; Haihong Zhong; Gulshan Ara; Joshua Cohen; Elise C Kohn
Secretory leukocyte protease inhibitor antagonizes paclitaxel in ovarian cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(2):600-9.
2010: Lokesh Jain; Tristan Sissung; Romano Danesi; Elise C Kohn; William L Dahut; Shivaani Kummar; David Venzon; David J Liewehr; Bevin C English; Caitlin E Baum; Robert Yarchoan; Giuseppe Giaccone; Jürgen Venitz; Douglas K Price; William D Figg
Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib.
Journal of experimental & clinical cancer research : CR 2010;29():95.
2010: Andrea K McCollum; Giovanna Casagrande; Elise C Kohn
Caught in the middle: the role of Bag3 in disease.
The Biochemical journal 2010;425(1):e1-3.
2009: Geoffrey Kim; Lucas Minig; Elise C Kohn
Proteomic profiling in ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19 Suppl 2():S2-6.
2009: Nilofer S Azad; Alyssa Perroy; Erin Gardner; Chiyo K Imamura; Cynthia Graves; Gisele Sarosy; Lori M Minasian; Herb Kotz; Miranda Raggio; William D Figg; Elise C Kohn
A phase I study of paclitaxel and continuous daily CAI in patients with refractory solid tumors.
Cancer biology & therapy 2009;8(19):1800-5.
2009: Jareer N Kassis; Victoria M Virador; Elizabeth A Guancial; Daniel Kimm; Allen S Ho; Mark Mishra; Eric Y Chuang; John Cook; David Gius; Elise C Kohn
Genomic and phenotypic analysis reveals a key role for CCN1 (CYR61) in BAG3-modulated adhesion and invasion.
The Journal of pathology 2009;218(4):495-504.
2009: Nick Devoogdt; Nabila Rasool; Ebony Hoskins; Fiona Simpkins; Nana Tchabo; Elise C Kohn
Overexpression of protease inhibitor-dead secretory leukocyte protease inhibitor causes more aggressive ovarian cancer in vitro and in vivo.
Cancer science 2009;100(3):434-40.
2009: Nilofer S Azad; Jeanny B Aragon-Ching; William L Dahut; Martin Gutierrez; William D Figg; Lokesh Jain; Seth M Steinberg; Maria L Turner; Elise C Kohn; Heidi H Kong
Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(4):1411-6.
2009: Wafic M Elmasri; Giovanna Casagrande; Ebony Hoskins; Daniel Kimm; Elise C Kohn
Cell adhesion in ovarian cancer.
Cancer treatment and research 2009;149():297-318.
2009: Victoria M Virador; Ben Davidson; Josephine Czechowicz; Alisha Mai; Jareer Kassis; Elise C Kohn
The anti-apoptotic activity of BAG3 is restricted by caspases and the proteasome.
PloS one 2009;4(4):e5136.
2008: Philip L Lorenzi; Jenny Llamas; Michele Gunsior; Laurent Ozbun; William C Reinhold; Sudhir Varma; Helen Ji; Hijoo Kim; Amy A Hutchinson; Elise C Kohn; Paul Goldsmith; Michael J Birrer; John N Weinstein
Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines.
Molecular cancer therapeutics 2008;7(10):3123-8.
2008: Robert L Coleman; Elise C Kohn
Rationale for combination use of targeted agents in ovarian cancer: do we have one?
Cancer 2008;113(4):665-7.
2008: Nilofer S Azad; Edwin M Posadas; Virginia E Kwitkowski; Seth M Steinberg; Lokesh Jain; Christina Annunziata; Lori Minasian; Gisele Sarosy; Herbert L Kotz; Ahalya Premkumar; Liang Cao; Deborah McNally; Catherine Chow; Helen X Chen; John J Wright; William D Figg; Elise C Kohn
Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(22):3709-14.
2008: Jia-Lin Yang; Xian-Jun Qu; Yan Yu; Elise C Kohn; Michael L Friedlander
Selective sensitivity to carboxyamidotriazole by human tumor cell lines with DNA mismatch repair deficiency.
International journal of cancer. Journal international du cancer 2008;123(2):258-63.
2008: Nilofer S Azad; Christina Annunziata; Seth M Steinberg; Lori M Minasian; Ahalya Premkumar; Catherine Chow; Herb Kotz; Elise C Kohn
Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy.
Cancer 2008;112(8):1726-32.
2008: Riccardo Alessandro; Simona Fontana; Margherita Giordano; Chiara Corrado; Paolo Colomba; Anna Maria Flugy; Alessandra Santoro; Elise C Kohn; Giacomo De Leo
Effects of carboxyamidotriazole on in vitro models of imatinib-resistant chronic myeloid leukemia.
Journal of cellular physiology 2008;215(1):111-21.
2008: Christina Annunziata; Nilofer S Azad; Amit S Dhamoon; Gordon R Whiteley; Elise C Kohn
Ovarian cancer in the proteomics era.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18 Suppl 1():1-6.
2008: Fiona Simpkins; Nick M Devoogdt; Nabila Rasool; Nana E Tchabo; Emilyn Alejandro; Mitchell M R N Kamrava; Elise C Kohn
The alarm anti-protease, secretory leukocyte protease inhibitor, is a proliferation and survival factor for ovarian cancer cells.
Carcinogenesis 2008;29(3):466-72.
2008: Ellen V Stevens; Satoshi Nishizuka; Smitha Antony; Mark Reimers; Sudhir Varma; Lynn Young; Peter J Munson; John N Weinstein; Elise C Kohn; Yves Pommier
Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers.
Molecular cancer therapeutics 2008;7(1):10-8.
2007: Christina Annunziata; Lilach Kleinberg; Ben Davidson; Aasmund Berner; David Gius; Nana Tchabo; Seth M Steinberg; Elise C Kohn
BAG-4/SODD and associated antiapoptotic proteins are linked to aggressiveness of epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(22 Pt 1):6585-92.
2007: Mary Winters; Bhavana Dabir; Minshu Yu; Elise C Kohn
Constitution and quantity of lysis buffer alters outcome of reverse phase protein microarrays.
Proteomics 2007;7(22):4066-8.
2007: Simona Fontana; Riccardo Alessandro; Marilisa Barranca; Margherita Giordano; Chiara Corrado; Isabelle Zanella-Cleon; Michel Becchi; Elise C Kohn; Giacomo De Leo
Comparative proteome profiling and functional analysis of chronic myelogenous leukemia cell lines.
Journal of proteome research 2007;6(11):4330-42.
2007: Andrew J Gunn; Yukihiro Hama; Yoshinori Koyama; Elise C Kohn; Peter L Choyke; Hisataka Kobayashi
Targeted optical fluorescence imaging of human ovarian adenocarcinoma using a galactosyl serum albumin-conjugated fluorophore.
Cancer science 2007;98(11):1727-33.
2007: Amit S Dhamoon; Elise C Kohn; Nilofer S Azad
The ongoing evolution of proteomics in malignancy.
Drug discovery today 2007;12(17-18):700-8.
2007: Edwin M Posadas; Virginia Kwitkowski; Herb Kotz; Virginia Espina; Lori M Minasian; Nana Tchabo; Ahalya Premkumar; Mahrukh M Hussain; Richard Chang; Seth M Steinberg; Elise C Kohn
A prospective analysis of imatinib-induced c-KIT modulation in ovarian cancer: a phase II clinical study with proteomic profiling.
Cancer 2007;110(2):309-17.
2007: Edwin M Posadas; Meghan S Liel; Virginia Kwitkowski; Lori M Minasian; Andrew K Godwin; Mahrukh M Hussain; Virginia Espina; Bradford J Wood; Seth M Steinberg; Elise C Kohn
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer.
Cancer 2007;109(7):1323-30.
2007: Elise C Kohn; Nilofer S Azad; Christina Annunziata; Amit S Dhamoon; Gordon R Whiteley
Proteomics as a tool for biomarker discovery.
Disease markers 2007;23(5-6):411-7.
2006: Philip L Lorenzi; William C Reinhold; Martina Rudelius; Michele Gunsior; Uma Shankavaram; Kimberly J Bussey; Uwe Scherf; Gabriel S Eichler; Scott E Martin; Koei Chin; Joe Gray; Elise C Kohn; Ivan D Horak; Daniel Von Hoff; Mark Raffeld; Paul Goldsmith; Natasha J Caplen; John N Weinstein
Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells.
Molecular cancer therapeutics 2006;5(11):2613-23.
2006: Nilofer S Azad; Nabila Rasool; Christina Annunziata; Lori M Minasian; Gordon R Whiteley; Elise C Kohn
Proteomics in clinical trials and practice: present uses and future promise.
Molecular & cellular proteomics : MCP 2006;5(10):1819-29.
2006: Jareer Kassis; Elizabeth A Guancial; Howard Doong; Victoria Virador; Elise C Kohn
CAIR-1/BAG-3 modulates cell adhesion and migration by downregulating activity of focal adhesion proteins.
Experimental cell research 2006;312(15):2962-71.
2006: Riccardo Alessandro; Maria Antonietta Di Bella; Anna Maria Flugy; Simona Fontana; Francesca Damiani; Chiara Corrado; Paolo Colomba; Matilde Todaro; Domenica Russo; Alessandra Santoro; Elise C Kohn; Giacomo De Leo
Comparative study of T84 and T84SF human colon carcinoma cells: in vitro and in vivo ultrastructural and functional characterization of cell culture and metastasis.
Virchows Archiv : an international journal of pathology 2006;449(1):48-61.
2006: Frances R Balkwill; Alan Ashworth; Robert C Bast; Jonathon S Berek; Jeff Boyd; Mary L Disis; Hani Gabra; Martin E Gore; Thomas C Hamilton; Ian J Jacobs; Stan B Kaye; Elise C Kohn; Gordon B Mills; Nicole D Urban
10th Biennial Helene Harris Memorial Trust meeting.
Cancer research 2006;66(6):2904-6.
2006: Ben Davidson; Virginia Espina; Seth M Steinberg; Vivi Ann Flørenes; Lance A Liotta; Gunnar Kristensen; Claes G Tropé; Aasmund Berner; Elise C Kohn
Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 1):791-9.
2006: William L Dahut; Nehal J Lakhani; James L Gulley; Philip M Arlen; Elise C Kohn; Herb Kotz; Debbie McNally; Allyson L Parr; Diana Nguyen; Sherry X Yang; Seth M Steinberg; Jürgen Venitz; Alex Sparreboom; William D Figg
Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors.
Cancer biology & therapy 2006;5(1):22-7.
2005: Lars P J Cruysberg; Alan J Franklin; Jason Sanders; Cindy Self; Peng Yuan; Karl G Csaky; Michael R Robinson; Elise C Kohn; Henry F Edelhauser
Effective transscleral delivery of two retinal anti-angiogenic molecules: carboxyamido-triazole (CAI) and 2-methoxyestradiol (2ME2).
Retina (Philadelphia, Pa.) 2005;25(8):1022-31.
2005: Nana Tchabo; Elizabeth A Guancial; Josephine A Czechowicz; Elise C Kohn
The role of proteomics in the diagnosis and treatment of ovarian cancer.
Women's health (London, England) 2005;1(3):365-74.
2005: Riccardo Alessandro; Simona Fontana; Elise C Kohn; Giacomo De Leo
Proteomic strategies and their application in cancer research.
Tumori 2005;91(6):447-55.
2005: E A Boyce; Elise C Kohn
Ovarian cancer in the proteomics era: diagnosis, prognosis, and therapeutics targets.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15 Suppl 3():266-73.
2005: Jareer Kassis; Julius Klominek; Elise C Kohn
Tumor microenvironment: what can effusions teach us?
Diagnostic cytopathology 2005;33(5):316-9.
2005: Elise C Kohn; L A Travers; Jareer Kassis; U Broome; Julius Klominek
Malignant effusions are sources of fibronectin and other promigratory and proinvasive components.
Diagnostic cytopathology 2005;33(5):300-8.
2005: Mitchell Kamrava; Fiona Simpkins; Emilyn Alejandro; Chad M Michener; Elizabeth Meltzer; Elise C Kohn
Lysophosphatidic acid and endothelin-induced proliferation of ovarian cancer cell lines is mitigated by neutralization of granulin-epithelin precursor (GEP), a prosurvival factor for ovarian cancer.
Oncogene 2005;24(47):7084-93.
2005: Fiona Simpkins; Josephine A Czechowicz; Lance A Liotta; Elise C Kohn
SELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics.
Pharmacogenomics 2005;6(6):647-53.
2005: Ellen V Stevens; Mark Raffeld; Virginia Espina; Gunnar Kristensen; Claes G Trope'; Elise C Kohn; Ben Davidson
Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinoma.
Cancer 2005;103(11):2313-9.
2005: Mary E Winters; Arpita I Mehta; Emanuel F Petricoin; Elise C Kohn; Lance A Liotta
Supra-additive growth inhibition by a celecoxib analogue and carboxyamido-triazole is primarily mediated through apoptosis.
Cancer research 2005;65(9):3853-60.
2005: Frank G E Perabo; André W Demant; Andreas Wirger; Doris H Schmidt; Mario Sitia; Eva Wardelmann; Stefan C Müller; Elise C Kohn
Carboxyamido-triazole (CAI) reverses the balance between proliferation and apoptosis in a rat bladder cancer model.
Anticancer research 2005;25(2A):725-9.
2005: Riccardo Alessandro; Claudio Belluco; Elise C Kohn
Proteomic approaches in colon cancer: promising tools for new cancer markers and drug target discovery.
Clinical colorectal cancer 2005;4(6):396-402.
2005: Stephan Hoffmann; Shikun He; Man Lin Jin; Laura Masiero; Peter Wiedemann; Stephen J Ryan; Elise C Kohn
Carboxyamido-triazole modulates retinal pigment epithelial and choroidal endothelial cell attachment, migration, proliferation, and MMP-2 secretion of choroidal endothelial cells.
Current eye research 2005;30(2):103-13.
2005: Nana Tchabo; Meghan S Liel; Elise C Kohn
Applying proteomics in clinical trials: assessing the potential and practical limitations in ovarian cancer.
American journal of pharmacogenomics : genomics-related research in drug development and clinical practice 2005;5(3):141-8.
2005: Edwin M Posadas; Fiona Simpkins; Lance A Liotta; C MacDonald; Elise C Kohn
Proteomic analysis for the early detection and rational treatment of cancer--realistic hope?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(1):16-22.
2004: Alan J Franklin; Thomas L Jetton; C Lynn Kuchemann; Stephen R Russell; Elise C Kohn
CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy.
Investigative ophthalmology & visual science 2004;45(10):3756-66.
2004: Frank G E Perabo; Andreas Wirger; Stefan Kamp; Heike Lindner; Doris H Schmidt; Stefan C Müller; Elise C Kohn
Carboxyamido-triazole (CAI), a signal transduction inhibitor induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2.
Anticancer research 2004;24(5A):2869-77.
2004: Edwin M Posadas; Ben Davidson; Elise C Kohn
Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature.
Current opinion in oncology 2004;16(5):478-84.
2004: Debra A Bell; Teri A Longacre; Jaime Prat; Elise C Kohn; Robert A Soslow; Lora Hedrick Ellenson; Anais Malpica; Mark H Stoler; Robert J Kurman
Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives.
Human pathology 2004;35(8):934-48.
2004: Thomas P Conrads; Vincent A Fusaro; Sally Ross; Donald J Johann; Vinodh Rajapakse; Ben A Hitt; Seth M Steinberg; Elise C Kohn; David A Fishman; G Whitely; J C Barrett; Lance A Liotta; Emanuel F Petricoin; Timothy D Veenstra
High-resolution serum proteomic features for ovarian cancer detection.
Endocrine-related cancer 2004;11(2):163-78.
2004: Ben Davidson; Emilyn Alejandro; Vivi Ann Flørenes; Jeanne-Mette Goderstad; Björn Risberg; Gunnar Kristensen; Claes G Trope; Elise C Kohn
Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma.
Cancer 2004;100(10):2139-47.
2004: Elise C Kohn; Yiling Lu; Hongwei Wang; Qinghua Yu; Shuangxing Yu; Hassan Hall; Debra L Smith; Funda Meric-Bernstam; Gabriel N Hortobagyi; Gordon B Mills
Molecular therapeutics: promise and challenges.
Seminars in oncology 2004;31(1 Suppl 3):39-53.
2004: Ellen V Stevens; Edwin M Posadas; Ben Davidson; Elise C Kohn
Proteomics in cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15 Suppl 4():iv167-71.
2003: Mahrukh M Hussain; Herb Kotz; Lori M Minasian; Ahalya Premkumar; Gisele Sarosy; Eddie Reed; Suoping Zhai; Seth M Steinberg; Miranda Raggio; Vyta Kulpa Oliver; William D Figg; Elise C Kohn
Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(23):4356-63.
2003: Ellen V Stevens; L A Liotta; Elise C Kohn
Proteomic analysis for early detection of ovarian cancer: a realistic approach?
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2003;13 Suppl 2():133-9.
2003: Gordon B Mills; Elise C Kohn; Yiling Lu; Astrid Eder; Xianjun Fang; Hongwei Wang; Robert C Bast; Joe Gray; Robert Jaffe; Gabriel Hortobagyi
Linking molecular diagnostics to molecular therapeutics: targeting the PI3K pathway in breast cancer.
Seminars in oncology 2003;30(5 Suppl 16):93-104.
2003: Vyta Kulpa Oliver; Angela M Patton; Sudhen Desai; Dominique Lorang; Steven Libutti; Elise C Kohn
Regulation of the pro-angiogenic microenvironment by carboxyamido-triazole.
Journal of cellular physiology 2003;197(1):139-48.
2003: Maria Fiammetta Romano; Michela Festa; Antonello Petrella; Alessasndra Rosati; Maria Pascale; Rita Bisogni; Vincenzo Poggi; Elise C Kohn; Salvatore Venuta; Maria Caterina Turco; Arturo Leone
BAG3 protein regulates cell survival in childhood acute lymphoblastic leukemia cells.
Cancer biology & therapy 2003;2(5):508-10.
2003: Paul C Herrmann; John W Gillespie; Lu Charboneau; Verena E Bichsel; Cloud P Paweletz; Valerie S Calvert; Elise C Kohn; Michael R Emmert-Buck; Lance A Liotta; Emanuel F Petricoin
Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer.
Proteomics 2003;3(9):1801-10.
2003: Howard Doong; Kathryn Rizzo; Shengyun Fang; Vyta Kulpa; Allan M Weissman; Elise C Kohn
CAIR-1/BAG-3 abrogates heat shock protein-70 chaperone complex-mediated protein degradation: accumulation of poly-ubiquitinated Hsp90 client proteins.
The Journal of biological chemistry 2003;278(31):28490-500.
2003: Christina Annunziata; Elise C Kohn
Is there a genomic basis for primary chemoresistance in ovarian cancer?
Gynecologic oncology 2003;90(1):1-2.
2003: Terry W Moody; Jessica Chiles; Elizabeth Moody; Gregory J Sieczkiewicz; Elise C Kohn
CAI inhibits the growth of small cell lung cancer cells.
Lung cancer (Amsterdam, Netherlands) 2003;39(3):279-88.
2003: M D'Amato; Anna Maria Flugy; Giuseppe Alaimo; B Bauder; Elise C Kohn; Giacomo De Leo; Riccardo Alessandro
Role of calcium in E-selectin induced phenotype of T84 colon carcinoma cells.
Biochemical and biophysical research communications 2003;301(4):907-14.
2003: Monica Brown Jones; Michele Spooner; Elise C Kohn
The granulin-epithelin precursor: a putative new growth factor for ovarian cancer.
Gynecologic oncology 2003;88(1 Pt 2):S136-9.
2003: Gordon B Mills; Xianjun Fang; Yiling Lu; Yutaka Hasegawa; Astrid Eder; Janos L Tanyi; Fazal H Tabassam; Muling Mao; Hongwei Wang; Kwai Wa Cheng; Yasuhisa Nakayama; Wenlin Kuo; Jim Erickson; David M Gershenson; Elise C Kohn; Robert Jaffe; Robert C Bast; Joe Gray
Specific keynote: molecular therapeutics in ovarian cancer.
Gynecologic oncology 2003;88(1 Pt 2):S88-92; discussion S93-6.
2003: Lance A Liotta; Emanuel F Petricoin; Ali Ardekani; Ben A Hitt; Peter J Levine; Vincent A Fusaro; Seth M Steinberg; Gordon B Mills; Charles Simone; David A Fishman; Elise C Kohn
General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer.
Gynecologic oncology 2003;88(1 Pt 2):S25-8; discussion S37-42.
2003: Angela M Patton; Jareer Kassis; Howard Doong; Elise C Kohn
Calcium as a molecular target in angiogenesis.
Current pharmaceutical design 2003;9(7):543-51.
2003: Monica Brown Jones; Chad M Michener; James O Blanchette; Vladimir Kuznetsov; Mark Raffeld; Ginette Serrero; Michael R Emmert-Buck; Emanuel F Petricoin; David B Krizman; Lance A Liotta; Elise C Kohn
The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):44-51.
2003: Lance A Liotta; Elise C Kohn
Cancer's deadly signature.
Nature genetics 2003;33(1):10-1.
2002: Howard Doong; Alysia Vrailas; Elise C Kohn
What's in the 'BAG'?--A functional domain analysis of the BAG-family proteins.
Cancer letters 2002;188(1-2):25-32.
2002: Emanuel F Petricoin; David K Ornstein; Cloud P Paweletz; Ali Ardekani; Paul S Hackett; Ben A Hitt; Alfredo Velassco; Christian Trucco; Laura Wiegand; Kamillah Wood; Charles B Simone; Peter J Levine; W Marston Linehan; Michael R Emmert-Buck; Seth M Steinberg; Elise C Kohn; Lance A Liotta
Serum proteomic patterns for detection of prostate cancer.
Journal of the National Cancer Institute 2002;94(20):1576-8.
2002: Andrew D Grove; Vinay V Prabhu; B Lynn Young; Frank C Lee; Vyta Kulpa; Peter J Munson; Elise C Kohn
Both protein activation and gene expression are involved in early vascular tube formation in vitro.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(9):3019-26.
2002: Emanuel F Petricoin; Kathy Zoon; Elise C Kohn; J Carl Barrett; Lance A Liotta
Clinical proteomics: translating benchside promise into bedside reality.
Nature reviews. Drug discovery 2002;1(9):683-95.
2002: Lance A Liotta; Elise C Kohn
Stromal therapy: the next step in ovarian cancer treatment.
Journal of the National Cancer Institute 2002;94(15):1113-4.
2002: Anna Maria Flugy; M D'Amato; Domenica Russo; Maria Antonietta Di Bella; Giuseppe Alaimo; Elise C Kohn; Giacomo De Leo; Riccardo Alessandro
E-selectin modulates the malignant properties of T84 colon carcinoma cells.
Biochemical and biophysical research communications 2002;293(3):1099-106.
2002: Emanuel F Petricoin; Ali Ardekani; Ben A Hitt; Peter J Levine; Vincent A Fusaro; Seth M Steinberg; Gordon B Mills; Charles Simone; David A Fishman; Elise C Kohn; Lance A Liotta
Use of proteomic patterns in serum to identify ovarian cancer.
Lancet 2002;359(9306):572-7.
2002: Chad M Michener; Ali Ardekani; Emanuel F Petricoin; Lance A Liotta; Elise C Kohn
Genomics and proteomics: application of novel technology to early detection and prevention of cancer.
Cancer detection and prevention 2002;26(4):249-55.
2002: Riccardo Alessandro; Elise C Kohn
Signal transduction targets in invasion.
Clinical & experimental metastasis 2002;19(3):265-73.
2002: Monica Brown Jones; Henry C Krutzsch; Hungjun Shu; Yingming Zhao; Lance A Liotta; Elise C Kohn; Emanuel F Petricoin
Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer.
Proteomics 2002;2(1):76-84.
2002: Gregory J Sieczkiewicz; Mahrukh Hussain; Elise C Kohn
Angiogenesis and metastasis.
Cancer treatment and research 2002;107():353-81.
2001: Elise C Kohn; Eddie Reed; Gisele Sarosy; Lori M Minasian; Kenneth S. Bauer; F Bostick-Bruton; Vyta Kulpa; Eiichi Fuse; AC Tompkins; MH Noone; Barry Goldspiel; James M Pluda; William D Figg; Lance A Liotta
A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(6):1600-9.
2001: Frank G E Perabo; S Kamp; D Schmidt; Heike Lindner; Gabriel Steiner; R H Mattes; Andreas Wirger; K Pegelow; Peter Albers; Elise C Kohn; Alexander von Ruecker; Stefan C Mueller
Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation.
British journal of cancer 2001;84(10):1330-8.
2001: KA Lapidos; Elisa C Woodhouse; Elise C Kohn; Laura Masiero
Mg(++)-induced endothelial cell migration: substratum selectivity and receptor-involvement.
Angiogenesis 2001;4(1):21-8.
2000: M R Brown; James O Blanchette; Elise C Kohn
Angiogenesis in ovarian cancer.
Baillière's best practice & research. Clinical obstetrics & gynaecology 2000;14(6):901-18.
2000: Howard Doong; J Price; Yong-Suk Kim; C Gasbarre; J Probst; Lance A Liotta; James O Blanchette; K Rizzo; Elise C Kohn
CAIR-1/BAG-3 forms an EGF-regulated ternary complex with phospholipase C-gamma and Hsp70/Hsc70.
Oncogene 2000;19(38):4385-95.
2000: M R Brown; Elise C Kohn; RV Hutter
The new millennium: applying novel technology to the study of the cancer cell in situ.
European journal of nuclear medicine 2000;27(1 Suppl):S27-30.
2000: M R Brown; Elise C Kohn; RV Hutter
The new millennium: applying novel technology to the study of the cancer cell in situ.
Cancer 2000;88(1):2-5.
1999: Laura Masiero; KA Lapidos; Indu S Ambudkar; Elise C Kohn
Regulation of the RhoA pathway in human endothelial cell spreading on type IV collagen: role of calcium influx.
Journal of cell science 1999;112 ( Pt 19)():3205-13.
1999: M R Brown; Rodrigo F Chuaqui; Cathy D Vocke; Andrew Berchuck; L P Middleton; Michael R Emmert-Buck; Elise C Kohn
Allelic loss on chromosome arm 8p: analysis of sporadic epithelial ovarian tumors.
Gynecologic oncology 1999;74(1):98-102.
1999: Victor A Sandor; Eddie Reed; Gisele Sarosy; L P Middleton; P Davis; Elise C Kohn
Synchronous inflammatory breast cancer and advanced ovarian carcinoma: a case with prolonged disease-free survival.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(5):585-8.
1998: Kenneth S. Bauer; Elise C Kohn; Richard M Lush; Seth M Steinberg; P Davis; David R Kohler; Eddie Reed; William D Figg
Pharmacokinetics and relative bioavailability of carboxyamido-triazole with respect to food and time of administration: use of a single model for simultaneous determination of changing parameters.
Journal of pharmacokinetics and biopharmaceutics 1998;26(6):673-87.
1998: L A Peterson; M R Brown; A J Carlisle; Elise C Kohn; Lance A Liotta; Michael R Emmert-Buck; David B Krizman
An improved method for construction of directionally cloned cDNA libraries from microdissected cells.
Cancer research 1998;58(23):5326-8.
1998: JD Shapiro; M L Rothenberg; Gisele Sarosy; Seth M Steinberg; D O Adamo; Eddie Reed; R F Ozols; Elise C Kohn
Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer.
Cancer 1998;83(9):1980-8.
1998: Riccardo Alessandro; Laura Masiero; KA Lapidos; JR Spoonster; Elise C Kohn
Endothelial cell spreading on type IV collagen and spreading-induced FAK phosphorylation is regulated by Ca2+ influx.
Biochemical and biophysical research communications 1998;248(3):635-40.
1997: H Yasui; Wayne G Butscher; M Cohen; N Spriggs; R Wersto; Elise C Kohn; Lance A Liotta; Kevin Gardner
Selective inhibition of mitogen-induced transactivation of the HIV long terminal repeat by carboxyamidotriazole. Calcium influx blockade represses HIV-1 transcriptional activation.
The Journal of biological chemistry 1997;272(45):28762-70.
1997: Y Wu; AJ Palad; WJ Wasilenko; Peter F Blackmore; W A Pincus; GL Schechter; JR Spoonster; Elise C Kohn; Kenneth D Somers
Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(11):1915-21.
1997: PA Lambert; Kenneth D Somers; Elise C Kohn; Roger R Perry
Antiproliferative and antiinvasive effects of carboxyamido-triazole on breast cancer cell lines.
Surgery 1997;122(2):372-8; discussion 378-9.
1997: JR Spoonster; Laura Masiero; S A Savage; J Probst; Elise C Kohn
Regulation of cell spreading during differentiation in the muscarinic M5 receptor tumor-suppressor model.
International journal of cancer. Journal international du cancer 1997;72(2):362-8.
1997: Riccardo Alessandro; Armanda Pugnaloni; G Biagini; Elise C Kohn
Regulation of cellular tyrosine phosphorylation by stimulatory and inhibitory muscarinic acetylcholine receptors.
Experimental cell research 1997;234(1):18-26.
1997: Elise C Kohn; William D Figg; Gisele Sarosy; Kenneth S. Bauer; P A Davis; M J Soltis; A Thompkins; Lance A Liotta; Eddie Reed
Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1985-93.
1997: William D Figg; Michaele C Christian; Richard M Lush; Charles J. Link; P Davis; Elise C Kohn; Gisele Sarosy; M L Rothenberg; R B Weiss; N Ryan; J Jacobs; Eddie Reed
Pharmacokinetics of elemental platinum (ultrafiltrate and total) after a thirty minute intravenous infusion of ormaplatin.
Biopharmaceutics & drug disposition 1997;18(4):347-59.
1997: W Jacobs; Tom Mikkelsen; R Smith; K Nelson; Mark L Rosenblum; Elise C Kohn
Inhibitory effects of CAI in glioblastoma growth and invasion.
Journal of neuro-oncology 1997;32(2):93-101.
1996: WJ Wasilenko; A J Palad; Kenneth D Somers; Peter F Blackmore; Elise C Kohn; J S Rhim; George L Wright; Paul F Schellhammer
Effects of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell lines.
International journal of cancer. Journal international du cancer 1996;68(2):259-64.
1996: Charles J. Link; E Reed; Gisele Sarosy; Elise C Kohn
Borderline ovarian tumors.
The American journal of medicine 1996;101(2):217-25.
1996: Elise C Kohn; Gisele Sarosy; P Davis; M Christian; C E Link; Frederick P Ognibene; W F Sindelar; J Jacob; Seth M Steinberg; A Premkumar; Eddie Reed
A phase I/II study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy of poor-prognosis advanced-stage epithelial ovarian cancer.
Gynecologic oncology 1996;62(2):181-91.
1996: Elise C Kohn; Riccardo Alessandro; J Probst; W Jacobs; E Brilley; Christian Felder
Identification and molecular characterization of a m5 muscarinic receptor in A2058 human melanoma cells. Coupling to inhibition of adenylyl cyclase and stimulation of phospholipase A2.
The Journal of biological chemistry 1996;271(29):17476-84.
1996: M J Soltis; H J Yeh; Kristina A Cole; N Whittaker; R Wersto; Elise C Kohn
Identification and characterization of human metabolites of CAI [5-amino-1-1(4'-chlorobenzoyl-3,5-dichlorobenzyl)-1,2,3-triazole- 4-carboxamide).
Drug metabolism and disposition: the biological fate of chemicals 1996;24(7):799-806.
1996: Eddie Reed; Gisele Sarosy; Elise C Kohn; M Christian; Charles J. Link; Barry Goldspiel; P Davis; J Jacob; M Maher
A phase I study of paclitaxel and cyclophosphamide in recurrent adenocarcinoma of the ovary.
Gynecologic oncology 1996;61(3):349-53.
1996: Charles J. Link; Elise C Kohn; E Reed
The relationship between borderline ovarian tumors and epithelial ovarian carcinoma: epidemiologic, pathologic, and molecular aspects.
Gynecologic oncology 1996;60(3):347-54.
1996: Riccardo Alessandro; L Masiero; Lance A Liotta; Elise C Kohn
The role of calcium in the regulation of invasion and angiogenesis.
In vivo (Athens, Greece) 1996;10(2):153-60.
1996: Elise C Kohn; Eddie Reed; Gisele Sarosy; M Christian; Charles J. Link; K Cole; William D Figg; P A Davis; J Jacob; Barry Goldspiel; Lance A Liotta
Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers.
Cancer research 1996;56(3):569-73.
1996: Riccardo Alessandro; J Spoonster; R Wersto; Elise C Kohn
Signal transduction as a therapeutic target.
Current topics in microbiology and immunology 1996;213 ( Pt 3)():167-88.
1996: Eddie Reed; R Bitton; Gisele Sarosy; Elise C Kohn
Paclitaxel dose intensity.
The Journal of infusional chemotherapy 1996;6(2):59-63.
1995: Riccardo Alessandro; Elise C Kohn
Molecular genetics of cancer. Tumor invasion and angiogenesis.
Cancer 1995;76(10):1874-7.
1995: Eddie Reed; Elise C Kohn; Gisele Sarosy; M Dabholkar; P Davis; J Jacob; M Maher
Paclitaxel, cisplatin, and cyclophosphamide in human ovarian cancer: molecular rationale and early clinical results.
Seminars in oncology 1995;22(3 Suppl 6):90-6.
1995: Elise C Kohn; Lance A Liotta
Molecular insights into cancer invasion: strategies for prevention and intervention.
Cancer research 1995;55(9):1856-62.
1995: Elise C Kohn; Riccardo Alessandro; J Spoonster; R Wersto; Lance A Liotta
Angiogenesis: role of calcium-mediated signal transduction.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(5):1307-11.
1995: Charles J. Link; Gisele Sarosy; Elise C Kohn; Michaele C Christian; P Davis; D O Adamo; Eddie Reed
Cutaneous manifestations of Taxol therapy.
Investigational new drugs 1995;13(3):261-3.
1994: Elise C Kohn; W Jacobs; Yong-Suk Kim; Riccardo Alessandro; William Stetler-Stevenson; Lance A Liotta
Calcium influx modulates expression of matrix metalloproteinase-2 (72-kDa type IV collagenase, gelatinase A).
The Journal of biological chemistry 1994;269(34):21505-11.
1994: K Cole; Elise C Kohn
Calcium-mediated signal transduction: biology, biochemistry, and therapy.
Cancer metastasis reviews 1994;13(1):31-44.
1994: Charles J. Link; A Bicher; Elise C Kohn; Michaele C Christian; P A Davis; D O Adamo; Eddie Reed; Gisele Sarosy
Flexible granulocyte colony-stimulating factor dosing in ovarian cancer patients who receive dose-intense taxol therapy.
Blood 1994;83(5):1188-92.
1994: Elise C Kohn; Christian Felder; W Jacobs; K A Holmes; A Day; R Freer; Lance A Liotta
Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAI.
Cancer research 1994;54(4):935-42.
1994: Elise C Kohn; Gisele Sarosy; A Bicher; Charles J. Link; M Christian; Seth M Steinberg; M Rothenberg; D O Adamo; P Davis; Frederick P Ognibene
Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer.
Journal of the National Cancer Institute 1994;86(1):18-24.
1993: Eddie Reed; John Janik; M A Bookman; M Rothenberg; J Smith; R C Young; R F Ozols; L VanderMolen; Elise C Kohn; J L Jacob
High-dose carboplatin and recombinant granulocyte-macrophage colony-stimulating factor in advanced-stage recurrent ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(11):2118-26.
1993: S M Jerian; Gisele Sarosy; Charles J. Link; H J Fingert; Eddie Reed; Elise C Kohn
Incapacitating autonomic neuropathy precipitated by taxol.
Gynecologic oncology 1993;51(2):277-80.
1993: K A Holmes; S Chaffins; B L Osborn; L A Liotta; Elise C Kohn
Quantitation of human plasma levels of the anticancer agent carboxyamidotriazole by high-performance liquid chromatography.
Journal of chromatography 1993;613(2):317-25.
1993: Elise C Kohn; G H Hollister; J D DiPersio; S Wahl; Lance A Liotta; E Schiffmann
Granulocyte-macrophage colony-stimulating factor induces human melanoma-cell migration.
International journal of cancer. Journal international du cancer 1993;53(6):968-72.
1993: A Bicher; Elise C Kohn; Gisele Sarosy; P Davis; D O Adamo; J Jacob; M Christian; Eddie Reed
The absence of cumulative bone marrow toxicity in patients with recurrent adenocarcinoma of the ovary receiving dose-intense taxol and granulocyte colony stimulating factor.
Anti-cancer drugs 1993;4(2):141-8.
1993: Elise C Kohn
Aging issues in invasion and metastasis. Fertile ground for investigation.
Cancer 1993;71(2 Suppl):552-7.
1993: A Bicher; Gisele Sarosy; Elise C Kohn; D O Adamo; P Davis; J Jacob; B A Chabner; Eddie Reed
Age does not influence taxol dose intensity in recurrent carcinoma of the ovary.
Cancer 1993;71(2 Suppl):594-600.
1992: Gisele Sarosy; Elise C Kohn; D A Stone; M Rothenberg; J Jacob; D O Adamo; Frederick P Ognibene; Robert Cunnion; Eddie Reed
Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(7):1165-70.
1992: Elise C Kohn; M A Sandeen; Lance A Liotta
In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates.
Cancer research 1992;52(11):3208-12.
1992: C P Minniti; Elise C Kohn; J H Grubb; W S Sly; Y Oh; H L Müller; Ronald G Rosenfeld; Lee Helman
The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cells.
The Journal of biological chemistry 1992;267(13):9000-4.
1990: V S Zabrenetzky; Elise C Kohn; David D Roberts
Suramin inhibits laminin- and thrombospondin-mediated melanoma cell adhesion and migration and binding of these adhesive proteins to sulfatide.
Cancer research 1990;50(18):5937-42.
1990: Elise C Kohn; E A Francis; Lance A Liotta; E Schiffmann
Heterogeneity of the motility responses in malignant tumor cells: a biological basis for the diversity and homing of metastatic cells.
International journal of cancer. Journal international du cancer 1990;46(2):287-92.
1990: O M El-Badry; C Minniti; Elise C Kohn; P J Houghton; W H Daughaday; Lee Helman
Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1990;1(7):325-31.
1990: Lance A Liotta; Elise C Kohn
Cancer invasion and metastases.
JAMA : the journal of the American Medical Association 1990;263(8):1123-6.
1990: Elise C Kohn; Lance A Liotta; E Schiffmann
Autocrine motility factor stimulates a three-fold increase in inositol trisphosphate in human melanoma cells.
Biochemical and biophysical research communications 1990;166(2):757-64.
1990: Elise C Kohn; Lance A Liotta
L651582: a novel antiproliferative and antimetastasis agent.
Journal of the National Cancer Institute 1990;82(1):54-60.
1990: Elise C Kohn; R G Steis; Edward A Sausville; S R Veach; J L Stocker; R Phelps; S Franco; Dan Longo; P A Bunn; D C Ihde
Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(1):155-60.
1988: Mary L Stracke; Elise C Kohn; S A Aznavoorian; L L Wilson; D Salomon; Henry C Krutzsch; Lance A Liotta; E Schiffmann
Insulin-like growth factors stimulate chemotaxis in human melanoma cells.
Biochemical and biophysical research communications 1988;153(3):1076-83.